Related Experiment Videos
Prophylaxis of fungal infections
1Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, Technischen Universität Dresden, FR Germany.
Abstract:
Considering the high morbidity and mortality of deep-seated opportunistic mycoses in severely immunosuppressed patients, strategies for prophylaxis appear to be indicated. Exposure to Aspergillus spp. can be prevented by air filtration which has been shown to reduce the rate of infection. However, Candida infections are predominantly caused by colonizing fungi; therefore drug prophylaxis is more promising. Prospective randomized studies proved the effectiveness of fluconazole (FLU) to prevent infections in patients after bone marrow transplantation.
Insights
Prophylaxis is crucial for severely immunocompromised patients facing opportunistic mycoses. Fluconazole (FLU) effectively prevents Candida infections in bone marrow transplant recipients, offering a promising drug strategy.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Hematology
Background:
- Opportunistic mycoses pose significant risks, leading to high morbidity and mortality in severely immunocompromised individuals.
- Preventing Aspergillus spp. infections can be achieved through environmental controls like air filtration.
- Candida infections, however, are often endogenous, making antifungal drug prophylaxis a more viable strategy.
Purpose of the Study:
- To evaluate the effectiveness of antifungal prophylaxis in severely immunocompromised patients.
- To identify optimal strategies for preventing opportunistic fungal infections, particularly in bone marrow transplant recipients.
Main Methods:
- Review of strategies for preventing opportunistic mycoses.
- Analysis of prospective randomized studies evaluating antifungal agents.
- Focus on drug prophylaxis for Candida infections.
Main Results:
- Air filtration effectively reduces Aspergillus spp. infection rates.
- Fluconazole (FLU) has demonstrated effectiveness in preventing Candida infections.
- Prospective randomized studies confirm fluconazole's efficacy in bone marrow transplant patients.
Conclusions:
- Antifungal drug prophylaxis, specifically fluconazole, is a promising strategy for preventing Candida infections in high-risk populations.
- Environmental controls are effective for airborne fungal pathogens like Aspergillus.
- Further research into prophylaxis for opportunistic mycoses in immunocompromised patients is warranted.